CZ238899A3 - Farmaceuticky aktivní tricyklické aminy - Google Patents

Farmaceuticky aktivní tricyklické aminy

Info

Publication number
CZ238899A3
CZ238899A3 CZ992388A CZ238899A CZ238899A3 CZ 238899 A3 CZ238899 A3 CZ 238899A3 CZ 992388 A CZ992388 A CZ 992388A CZ 238899 A CZ238899 A CZ 238899A CZ 238899 A3 CZ238899 A3 CZ 238899A3
Authority
CZ
Czechia
Prior art keywords
pharmaceutically active
tricyclic amines
active tricyclic
amines
pyrimido
Prior art date
Application number
CZ992388A
Other languages
English (en)
Other versions
CZ288076B6 (cs
Inventor
Gordon L. Bundy
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of CZ238899A3 publication Critical patent/CZ238899A3/cs
Publication of CZ288076B6 publication Critical patent/CZ288076B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
CZ19992388A 1997-01-08 1997-12-19 Tricyklické aminy a meziprodukty pro jejich přípravu CZ288076B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3522397P 1997-01-08 1997-01-08
US4374997P 1997-04-09 1997-04-09

Publications (2)

Publication Number Publication Date
CZ238899A3 true CZ238899A3 (cs) 1999-10-13
CZ288076B6 CZ288076B6 (cs) 2001-04-11

Family

ID=26711898

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ19992388A CZ288076B6 (cs) 1997-01-08 1997-12-19 Tricyklické aminy a meziprodukty pro jejich přípravu

Country Status (22)

Country Link
US (1) US5932728A (cs)
EP (1) EP0964865B1 (cs)
JP (1) JP2002511061A (cs)
KR (1) KR20000069940A (cs)
CN (1) CN1128798C (cs)
AT (1) ATE233763T1 (cs)
AU (1) AU723709B2 (cs)
CA (1) CA2275389A1 (cs)
CZ (1) CZ288076B6 (cs)
DE (1) DE69719563T2 (cs)
DK (1) DK0964865T3 (cs)
ES (1) ES2193424T3 (cs)
FI (1) FI991568A7 (cs)
HU (1) HUP0003692A3 (cs)
NO (1) NO312463B1 (cs)
NZ (1) NZ336659A (cs)
PL (1) PL334451A1 (cs)
PT (1) PT964865E (cs)
RU (1) RU2200737C2 (cs)
SI (1) SI0964865T1 (cs)
SK (1) SK283378B6 (cs)
WO (1) WO1998042708A2 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7345051B2 (en) 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
ATE355836T1 (de) * 2000-01-31 2007-03-15 Genaera Corp Inhibitoren der mucin-synthese
JP2005515173A (ja) * 2001-10-31 2005-05-26 バイエル・ヘルスケア・アクチェンゲゼルシャフト ピリミド［４，５−ｂ］インドール誘導体
WO2004058764A1 (en) * 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
ES2736200T3 (es) * 2009-07-22 2019-12-26 Univ Illinois Inhibidores de HDAC y métodos terapéuticos que utilizan los mismos
EP2686320B1 (en) 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
EP2807165B1 (en) 2012-01-27 2019-05-15 Université de Montréal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
KR102278306B1 (ko) 2015-06-05 2021-07-15 헤마-퀘벡 조혈 줄기세포를 전구 세포로 배양 및/또는 분화시키는 방법 및 그의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150941T3 (es) * 1992-04-03 2000-12-16 Upjohn Co Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
NZ304519A (en) * 1995-03-02 2000-01-28 Upjohn Co Pydrimido[4,5-b]indoles

Also Published As

Publication number Publication date
RU2200737C2 (ru) 2003-03-20
HK1023344A1 (en) 2000-09-08
WO1998042708A2 (en) 1998-10-01
ES2193424T3 (es) 2003-11-01
US5932728A (en) 1999-08-03
DE69719563D1 (de) 2003-04-10
AU8655498A (en) 1998-10-20
FI991568L (fi) 1999-07-08
CN1239961A (zh) 1999-12-29
FI991568A7 (fi) 1999-07-08
SK90199A3 (en) 2000-05-16
CZ288076B6 (cs) 2001-04-11
JP2002511061A (ja) 2002-04-09
CA2275389A1 (en) 1998-10-01
HUP0003692A2 (hu) 2001-04-28
NZ336659A (en) 2001-01-26
SK283378B6 (sk) 2003-06-03
NO993359D0 (no) 1999-07-07
NO993359L (no) 1999-09-07
DE69719563T2 (de) 2003-11-27
AU723709B2 (en) 2000-09-07
PL334451A1 (en) 2000-02-28
EP0964865B1 (en) 2003-03-05
HUP0003692A3 (en) 2002-10-28
EP0964865A2 (en) 1999-12-22
ATE233763T1 (de) 2003-03-15
SI0964865T1 (en) 2003-08-31
DK0964865T3 (da) 2003-05-05
PT964865E (pt) 2003-06-30
WO1998042708A3 (en) 1998-12-17
KR20000069940A (ko) 2000-11-25
NO312463B1 (no) 2002-05-13
CN1128798C (zh) 2003-11-26

Similar Documents

Publication Publication Date Title
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
PL319833A1 (en) Compounds and composition for carrying active media
CA2086434A1 (en) Quinuclidine derivatives
HUT50767A (en) Process for producing new 1,3,4,5-tetrahydro-benz/c,d/indole derivatives and pharmaceutical compositions comprising such compounds
GB9911053D0 (en) 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
AU1945795A (en) Thieno{ 2,3-b}indoles, their preparation and use
ATE38227T1 (de) Pharmakologisch aktive derivate von pyrido(1,5)benzodiazepinon.
CZ238899A3 (cs) Farmaceuticky aktivní tricyklické aminy
EE03830B1 (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetodid ja kasutamine raviks
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
HU9700708D0 (en) Pyrimido[1,2-a]indole derivatives and process for producing them
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
HUP0102936A3 (en) New process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3-acetamide and salts thereof
CA2298820A1 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
FI894506L (fi) Menetelmä valmistaa terapeuttisesti aktiivisia pyrido/1,2-a/indolijohdannaisia
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
IE840119L (en) Pyrido indoles
CA2303132A1 (en) Intranasal formulations containing scopolamine and method of treating motion sickness
YU32691A (sh) 6-supstituisani-heksahidrobenz c,d indoli i postupak za njegovo dobijanje
DE60036955D1 (de) HERSTELLUNG VON i3,5,7ö-1H-IMIDAZOi1,5-AöIMIDAZOL-2(3H)-ON-VERBINDUNGEN
CA2241852A1 (en) Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
IS3938A (is) Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær
CA2180155A1 (en) Naphthylamides as central nervous system agents

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20051219